Skip to main content
Erschienen in: Clinical Rheumatology 1/2016

01.01.2016 | Original Article

Genetic variation in the ABCG2 gene is associated with gout risk in the Chinese Han population

verfasst von: Mutu Jiri, Le Zhang, Bing Lan, Na He, Tian Feng, Kai Liu, Tianbo Jin, Longli Kang

Erschienen in: Clinical Rheumatology | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Abstract

Gout is a common type of arthritis that is characterized by hyperuricemia, tophi, and joint inflammation. Current evidence suggests that heredity contributes to the progression of gout. Previous studies have shown that regulation of the ATP-binding cassette subfamily G member 2 (ABCG2) pathways plays a role in gout occurrence. To investigate and validate potential genetic associations with the risk of gout, we conducted a case–control study. We conducted 143 cases and 310 controls and genotyped seven single-nucleotide polymorphisms (SNPs) in ABCG2 gene. ABCG2 SNP association analyses were performed using SPSS 17.0 Statistical Package, PLINK Software, HaploView software package, and SHEsis software platform. We identified that four susceptibility SNPs were potentially associated with occurrence of gout. Rs2622621 and rs3114018 in ABCG2 can actually increase the risk of gout in log-additive model (rs2622621, odds ratio (OR) = 1.90, 95 % confidence interval (CI) 1.39–2.61, p < 0.001; rs3114018, OR = 1.55, 95 % CI 1.13–2.13, p = 0.006). We found that rs17731799G/T-G/G and rs3114020 T/C-T/T in ABCG2 can actually increase the risk of gout in dominant model (rs17731799, OR = 1.67, 95 % CI 1.05–2.66, p = 0.028; rs3114020, OR = 1.58, 95 % CI 1.00–2.51, p = 0.048). The ABCG2 haplotype “GGCTCTC” (OR = 0.46, 95 % CI 0.28–0.75, p = 0.0019) decreased the gout risk. Our results, combined with those from previous studies, suggest that genetic variation in ABCG2 may influence gout susceptibility in the Han population.
Literatur
1.
Zurück zum Zitat Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z et al (2008) Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35(9):1859–1864PubMed Miao Z, Li C, Chen Y, Zhao S, Wang Y, Wang Z et al (2008) Dietary and lifestyle changes associated with high prevalence of hyperuricemia and gout in the Shandong coastal cities of Eastern China. J Rheumatol 35(9):1859–1864PubMed
2.
3.
Zurück zum Zitat Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P et al (2006) EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65(10):1301–1311PubMedPubMedCentralCrossRef Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P et al (2006) EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 65(10):1301–1311PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Wang B, Miao Z, Liu S, Wang J, Zhou S, Han L et al (2010) Genetic analysis of ABCG2 gene C421A polymorphism with gout disease in Chinese Han male population. Hum Genet 127(2):245–246PubMedCrossRef Wang B, Miao Z, Liu S, Wang J, Zhou S, Han L et al (2010) Genetic analysis of ABCG2 gene C421A polymorphism with gout disease in Chinese Han male population. Hum Genet 127(2):245–246PubMedCrossRef
5.
Zurück zum Zitat Choi HK, Ford ES, Li C, Curhan G (2007) Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 57(1):109–115PubMedCrossRef Choi HK, Ford ES, Li C, Curhan G (2007) Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 57(1):109–115PubMedCrossRef
6.
Zurück zum Zitat Choi HK, De Vera MA, Krishnan E (2008) Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford, England) 47(10):1567–1570CrossRef Choi HK, De Vera MA, Krishnan E (2008) Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile. Rheumatology (Oxford, England) 47(10):1567–1570CrossRef
8.
Zurück zum Zitat Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F et al (2008) Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372(9654):1953–1961PubMedPubMedCentralCrossRef Dehghan A, Kottgen A, Yang Q, Hwang SJ, Kao WL, Rivadeneira F et al (2008) Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study. Lancet 372(9654):1953–1961PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Woodward OM, Kottgen A, Coresh J, Boerwinkle E, Guggino WB, Kottgen M (2009) Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A 106(25):10338–10342PubMedPubMedCentralCrossRef Woodward OM, Kottgen A, Coresh J, Boerwinkle E, Guggino WB, Kottgen M (2009) Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci U S A 106(25):10338–10342PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Ichida K, Matsuo H, Takada T, Nakayama A, Murakami K, Shimizu T et al (2012) Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun 3:764PubMedPubMedCentralCrossRef Ichida K, Matsuo H, Takada T, Nakayama A, Murakami K, Shimizu T et al (2012) Decreased extra-renal urate excretion is a common cause of hyperuricemia. Nat Commun 3:764PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Gabriel S, Ziaugra L, Tabbaa D (2009) SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet 2.12. 1–2.. 6 Gabriel S, Ziaugra L, Tabbaa D (2009) SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet 2.12. 1–2.. 6
12.
Zurück zum Zitat Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM et al (2007) High-throughput oncogene mutation profiling in human cancer. Nat Genet 39(3):347–351PubMedCrossRef Thomas RK, Baker AC, Debiasi RM, Winckler W, Laframboise T, Lin WM et al (2007) High-throughput oncogene mutation profiling in human cancer. Nat Genet 39(3):347–351PubMedCrossRef
13.
Zurück zum Zitat Adamec C (1964) Example of the use of the nonparametric test. Test X2 for comparison of 2 independent examples. Ceskoslovenske zdravotnictvi 12:613–619PubMed Adamec C (1964) Example of the use of the nonparametric test. Test X2 for comparison of 2 independent examples. Ceskoslovenske zdravotnictvi 12:613–619PubMed
15.
Zurück zum Zitat Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics (Oxford, England) 22(15):1928–1929CrossRef Sole X, Guino E, Valls J, Iniesta R, Moreno V (2006) SNPStats: a web tool for the analysis of association studies. Bioinformatics (Oxford, England) 22(15):1928–1929CrossRef
16.
Zurück zum Zitat Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J et al (2008) Disease-related and all-cause health care costs of elderly patients with gout. J Manag Care Pharm 14(2):164–175PubMed Wu EQ, Patel PA, Yu AP, Mody RR, Cahill KE, Tang J et al (2008) Disease-related and all-cause health care costs of elderly patients with gout. J Manag Care Pharm 14(2):164–175PubMed
17.
Zurück zum Zitat Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M et al (2009) Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 5(6), e1000504PubMedPubMedCentralCrossRef Kolz M, Johnson T, Sanna S, Teumer A, Vitart V, Perola M et al (2009) Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 5(6), e1000504PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Stark K, Reinhard W, Grassl M, Erdmann J, Schunkert H, Illig T et al (2009) Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. PLoS One 4(11), e7729PubMedPubMedCentralCrossRef Stark K, Reinhard W, Grassl M, Erdmann J, Schunkert H, Illig T et al (2009) Common polymorphisms influencing serum uric acid levels contribute to susceptibility to gout, but not to coronary artery disease. PLoS One 4(11), e7729PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Matsuo H, Takada T, Ichida K, Nakamura T, Nakayama A, Ikebuchi Y et al (2009) Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med 1(5):5ra11PubMedCrossRef Matsuo H, Takada T, Ichida K, Nakamura T, Nakayama A, Ikebuchi Y et al (2009) Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population. Sci Transl Med 1(5):5ra11PubMedCrossRef
20.
Zurück zum Zitat Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH et al (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61(8):3458–3464PubMed Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH et al (2001) Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61(8):3458–3464PubMed
21.
Zurück zum Zitat Huls M, Brown CD, Windass AS, Sayer R, van den Heuvel JJ, Heemskerk S et al (2008) The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int 73(2):220–225PubMedCrossRef Huls M, Brown CD, Windass AS, Sayer R, van den Heuvel JJ, Heemskerk S et al (2008) The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int 73(2):220–225PubMedCrossRef
22.
Zurück zum Zitat Matsuo H, Ichida K, Takada T, Nakayama A, Nakashima H, Nakamura T et al (2013) Common dysfunctional variants in ABCG2 are a major cause of early-onset gout. Sci Rep 3:2014PubMedPubMedCentralCrossRef Matsuo H, Ichida K, Takada T, Nakayama A, Nakashima H, Nakamura T et al (2013) Common dysfunctional variants in ABCG2 are a major cause of early-onset gout. Sci Rep 3:2014PubMedPubMedCentralCrossRef
Metadaten
Titel
Genetic variation in the ABCG2 gene is associated with gout risk in the Chinese Han population
verfasst von
Mutu Jiri
Le Zhang
Bing Lan
Na He
Tian Feng
Kai Liu
Tianbo Jin
Longli Kang
Publikationsdatum
01.01.2016
Verlag
Springer London
Erschienen in
Clinical Rheumatology / Ausgabe 1/2016
Print ISSN: 0770-3198
Elektronische ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-015-3105-9

Weitere Artikel der Ausgabe 1/2016

Clinical Rheumatology 1/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.